Recombinant Human VEGF-D (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
Vascular endothelial growth factor D, c-Fos-induced growth factor, FIGF
VEGF-D_Human_RECOM_BA_053116
Human VEGF-D induces the proliferation of HMVEC human microvascular endothelial cells in a dose dependent manner.
  • VEGF-D_Human_RECOM_BA_053116
    Human VEGF-D induces the proliferation of HMVEC human microvascular endothelial cells in a dose dependent manner.
Cat # Size Price Quantity Check Availability
760501 2 µg $89.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
760502 10 µg $223.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote

This product is not available for shipping outside of the United States.

Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.

Description

Vascular endothelial growth factor D (VEGF-D), also known as c-fos-induced growth factor (FIGF), is a member of the VEGF family. VEGF-D is structurally similar to VEGF-C and both are specific ligands for the tyrosine kinase receptor VEGFR-3 (flt-4). They are both secreted as non-covalent homodimers. The secreted VEGF-D undergoes a complex proteolytic process enabling it to also act as a ligand for VEGFR-2 (KDR/flk-1). VEGF-D is expressed in adult lungs, heart, muscles, and small intestines. It is most abundantly expressed in the fetal lungs and skin. VEGF-D exhibits mitogenic effects on vascular and lymphatic endothelial cells. VEGF-D functions in the formation of the venous and lymphatic vascular systems during embryogenesis and in the maintenance of differentiated lymphatic endothelium in adults. Both VEGF-C and VEGF-D are over-expressed in certain cancers and promote tumor lymphangiogenesis. TGF-β1 has been shown to downregulate VEGF-D expression in human lung fibroblasts.

Technical data sheet

Product Details

Source
Human VEGF-D, amino acids (Phe89-Arg205) (Accession# O43915), was expressed in HEK293.
Molecular Mass
The 117 amino acid recombinant protein has a predicted molecular mass of approximately 13.1 kD. The protein migrates at approximately 20-22 kD under non-reducing conditions by SDS-PAGE. The predicted N-terminal amino acid is Phe.
Purity
>95%, as determined by SDS-PAGE gel and HPLC analysis.
Formulation
Lyophilized from 0.2 µm filtered protein solution in 10 mM Sodium Citrate, pH 4.0.
Endotoxin Level
Less than 1.0 EU per µg protein as determined by the LAL method.
Storage & Handling
Unopened vial can be stored at -20°C or -70°C. For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-0.5 mg/ml. Do not vortex. It is recommended to further dilute in a buffer containing a carrier protein such as 0.1% BSA and store working aliquots at -20°C to -80°C. Avoid repeated freeze/thaw cycles.
Activity
ED50 = 0.15 — 0.6 µg/mL as measured by the ability of the protein to induce proliferation of HMVEC.
Application

Bioassay

Antigen Details

Structure
Non-covalent homodimer.
Distribution
VEGF-D is expressed in the adult lungs, heart, muscles, and small intestines; it is most abundantly expressed in the fetal heart and lungs and skin.
Function
VEGF-D plays a key role in lymphangiogenesis, stimulates the migration, proliferation, and the survival of human endothelial cells.
Interaction
Lymphatic endothelial cells and vascular endothelial cells.
Ligand/Receptor
VEGF-R3, VEGF-R2, and Neuropilin-1.
Bioactivity
Measured by the ability of humanVEGF-D to induce the proliferation of HMVEC human microvascular endothelial cells.
Cell Type
Neural Stem Cells, Mesenchymal Stem Cells, Hematopoietic stem and progenitors
Biology Area
Cell Biology, Neuroscience, Stem Cells, Synaptic Biology, Angiogenesis, Stem Cells
Molecular Family
Growth Factors, Cytokines/Chemokines
Antigen References

1. Yamada Y, et al. 1997. Genomics 42:483-488.
2. Achen MG, et al. 1998. Proc. Natl. Acad. Sci. USA 2:548-553.
3. Stacker SA, et al. 2001. Nat. Med. 2:186-91.
4. Duff SE, et al. 2003. Br. J. Cancer 89:426-430.
5. Tammela T, et al.  2005. Cardiovasc. Res. 65:550-563.
6. Roy H, et al. 2006. FEBS Letters 580:2879-87.
7. Cui Y, et al. 2014. Mol. Med. 20:120-134.

Gene ID
2277 View all products for this Gene ID
UniProt
View information about VEGF-D on UniProt.org
Go To Top Version: 1    Revision Date: 05/31/2016

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login/Register
Forgot your password? Reset Password
Request an Account